Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation

Clinical and Translational Immunology

Volumn 4, Issue , 2015, Pages

  Holmes Liew, Chien Li ^a,b   Holmes, Mark ^a,b   Beagley, Leone ^c   Hopkins, Peter ^d,e   Chambers, Daniel ^d,e   Smith, Corey ^c   Khanna, Rajiv ^c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d THE PRINCE CHARLES HOSPITAL   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; EVEROLIMUS; FOSCARNET; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; LEFLUNOMIDE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; TACROLIMUS;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; LONG TERM SURVIVAL; LUNG LAVAGE; LUNG TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 85048824473     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/cti.2015.2     Document Type: Article

References (19)

1. Mitsani D, Nguyen MH, Kwak EJ, Silveira FP, Vadnerkar A, Pilewski J et al. Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis. J Heart Lung Transplant 2010; 29: 1014-1020.
2. Valentine VG, Bonvillain RW, Gupta MR, Lombard GA, LaPlace SG, Dhillon GS et al. Infections in lung allograft recipients: ganciclovir era. J Heart Lung Transplant 2008; 27: 528-535.
3. Ettinger NA, Bailey TC, Trulock EP, Storch GA, Anderson D, Raab S et al. Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis 1993; 147: 1017-1023.
4. Keenan RJ, Lega ME, Dummer JS, Paradis IL, Dauber JH, Rabinowich H et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433-438.
5. Duncan SR, Paradis IL, Yousem SA, Similo SL, Grgurich WF, Williams PA et al. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 1992; 146: 1419-1425.
6. Bhorade SM, Lurain NS, Jordan A, Leischner J, Villanueva J, Durazo R et al. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant 2002; 21: 1274-1282.
7. Razonable RR, Humar A. Practice ASTIDCo. Cytomegalovirus in solid organ transplantation. Am J Transplant 2013; 13: 93-106.
8. Le Page AK, Jager MM, Iwasenko JM, Scott GM, Alain S, Rawlinson WD. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients. Clin Infect Dis 2013; 56: 1018-1029.
9. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89: 779-795.
10. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 2010; 23: 689-712.
11. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant 2008; 22: 162-170.
12. Mylonakis E, Kallas WM, Fishman JA. Combination antiviral therapy for ganciclovirresistant cytomegalovirus infection in solid-organ transplant recipients. Clin Infect Dis 2002; 34: 1337-1341.
13. Hadaya K, de Rham C, Bandelier C, Bandelier C, Ferrari-Lacraz S, Jendly S et al. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant 2008; 8: 2674-2683.
14. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202: 673-685.
15. Tey SK. Adoptive T-cell therapy: adverse events and safety switches. Clin Transl Immunol 2014; 3: e17.
16. Tzannou I, Leen AM. Accelerating immune reconstitution after hematopoietic stem cell transplantation. Clin Transl Immunol 2014; 3: e11.
17. Brestrich G, Zwinger S, Fischer A, Schmuck M, Rohmhild A, Hammer MH et al. Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy. Am J Transplant 2009; 9: 1679-1684.
18. Elkington R, Walker S, Crough T, Menzies M, Tellam J, Bharadwaj M et al. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 2003; 77: 5226-5240.
19. Hill GR, Tey SK, Beagley L, Crough T, Morton JA, Clouston AD et al. Successful immunotherapy of HCMV disease using virus-specific T cells expanded from an allogeneic stem cell transplant recipient. Am J Transplant 2010; 10: 173-179.